452 related articles for article (PubMed ID: 26765786)
1. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
Jansook P; Pichayakorn W; Muankaew C; Loftsson T
Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
[TBL] [Abstract][Full Text] [Related]
2. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
Jansook P; Ritthidej GC; Ueda H; Stefánsson E; Loftsson T
J Pharm Pharm Sci; 2010; 13(3):336-50. PubMed ID: 21092707
[TBL] [Abstract][Full Text] [Related]
3. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
[TBL] [Abstract][Full Text] [Related]
4. CDs as solubilizers: effects of excipients and competing drugs.
Jansook P; Loftsson T
Int J Pharm; 2009 Sep; 379(1):32-40. PubMed ID: 19524652
[TBL] [Abstract][Full Text] [Related]
5. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
[TBL] [Abstract][Full Text] [Related]
6. gammaCD/HPgammaCD: synergistic solubilization.
Jansook P; Loftsson T
Int J Pharm; 2008 Nov; 363(1-2):217-9. PubMed ID: 18691643
[TBL] [Abstract][Full Text] [Related]
7. Development of eye drops containing antihypertensive drugs: formulation of aqueous irbesartan/γCD eye drops.
Jansook P; Muankaew C; Stefánsson E; Loftsson T
Pharm Dev Technol; 2015; 20(5):626-32. PubMed ID: 24754413
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled γ-cyclodextrin as nanocarriers for enhanced ocular drug bioavailability.
Jansook P; Loftsson T
Int J Pharm; 2022 Apr; 618():121654. PubMed ID: 35278603
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
Loftsson T; Hreinsdóttir D; Stefánsson E
J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
[TBL] [Abstract][Full Text] [Related]
10. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.
Nogueiras-Nieto L; Sobarzo-Sánchez E; Gómez-Amoza JL; Otero-Espinar FJ
Eur J Pharm Biopharm; 2012 Apr; 80(3):585-95. PubMed ID: 22182528
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activity of econazole nitrate/cyclodextrin complex: Effect of pH and formation of complex aggregates.
Jansook P; Prajapati M; Pruksakorn P; Loftsson T
Int J Pharm; 2020 Jan; 574():118896. PubMed ID: 31765779
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrins as solubilizers: formation of complex aggregates.
Jansook P; Kurkov SV; Loftsson T
J Pharm Sci; 2010 Feb; 99(2):719-29. PubMed ID: 19670293
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone eye drops containing γ-cyclodextrin-based nanogels.
Moya-Ortega MD; Alves TF; Alvarez-Lorenzo C; Concheiro A; Stefánsson E; Thorsteinsdóttir M; Loftsson T
Int J Pharm; 2013 Jan; 441(1-2):507-15. PubMed ID: 23149258
[TBL] [Abstract][Full Text] [Related]
14. Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles.
Jóhannsdóttir S; Kristinsson JK; Fülöp Z; Ásgrímsdóttir G; Stefánsson E; Loftsson T
Int J Pharm; 2017 Aug; 529(1-2):486-490. PubMed ID: 28720540
[TBL] [Abstract][Full Text] [Related]
15. A New Approach for Quantitative Determination of γ-Cyclodextrin in Aqueous Solutions: Application in Aggregate Determinations and Solubility in Hydrocortisone/γ-Cyclodextrin Inclusion Complex.
Saokham P; Loftsson T
J Pharm Sci; 2015 Nov; 104(11):3925-3933. PubMed ID: 26249751
[TBL] [Abstract][Full Text] [Related]
16. Baicalein and hydroxypropyl-γ-cyclodextrin complex in poloxamer thermal sensitive hydrogel for vaginal administration.
Zhou Q; Zhong L; Wei X; Dou W; Chou G; Wang Z
Int J Pharm; 2013 Sep; 454(1):125-34. PubMed ID: 23850236
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled cyclodextrin aggregates and nanoparticles.
Messner M; Kurkov SV; Jansook P; Loftsson T
Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
[TBL] [Abstract][Full Text] [Related]
19. Effect of porcine pancreatic α-amylase on dexamethasone release from aqueous solution containing natural γ-cyclodextrin.
Sripetch S; Jansook P; Loftsson T
Int J Pharm; 2020 Jul; 585():119452. PubMed ID: 32464233
[TBL] [Abstract][Full Text] [Related]
20. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
